ATE226206T1 - Benzoxazine zur erhöhung der synaptischen reaktionen - Google Patents

Benzoxazine zur erhöhung der synaptischen reaktionen

Info

Publication number
ATE226206T1
ATE226206T1 AT97919965T AT97919965T ATE226206T1 AT E226206 T1 ATE226206 T1 AT E226206T1 AT 97919965 T AT97919965 T AT 97919965T AT 97919965 T AT97919965 T AT 97919965T AT E226206 T1 ATE226206 T1 AT E226206T1
Authority
AT
Austria
Prior art keywords
compounds
subjects
ampa receptors
benzoxazine
reactions
Prior art date
Application number
AT97919965T
Other languages
English (en)
Inventor
Gary A Rogers
Gary S Lynch
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE226206T1 publication Critical patent/ATE226206T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97919965T 1996-04-03 1997-03-28 Benzoxazine zur erhöhung der synaptischen reaktionen ATE226206T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/624,335 US5736543A (en) 1996-04-03 1996-04-03 Benzoxazines for enhancing synaptic response
PCT/US1997/005184 WO1997036907A1 (en) 1996-04-03 1997-03-28 Benzoxazines for enhancing synaptic response

Publications (1)

Publication Number Publication Date
ATE226206T1 true ATE226206T1 (de) 2002-11-15

Family

ID=24501596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919965T ATE226206T1 (de) 1996-04-03 1997-03-28 Benzoxazine zur erhöhung der synaptischen reaktionen

Country Status (10)

Country Link
US (2) US5736543A (de)
EP (1) EP0891365B1 (de)
JP (1) JP3170294B2 (de)
AT (1) ATE226206T1 (de)
AU (1) AU708212B2 (de)
DE (1) DE69716414T2 (de)
DK (1) DK0891365T3 (de)
ES (1) ES2185932T3 (de)
NZ (1) NZ331992A (de)
WO (1) WO1997036907A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU721936B2 (en) * 1996-04-03 2000-07-20 Regents Of The University Of California, The Benzoxazines for enhancing synaptic response
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses
CN1281335A (zh) * 1997-10-27 2001-01-24 科泰克斯药物股份有限公司 用安哌克和精神安定剂治疗精神***症
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response
US6943159B1 (en) 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
US6124278A (en) * 1998-04-03 2000-09-26 The Regents Of The University Of California Acylbenzoxazines for enhancing synaptic response
US6011991A (en) * 1998-12-07 2000-01-04 Technology Patents, Llc Communication system and method including brain wave analysis and/or use of brain activity
US7455836B2 (en) * 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
TWI232863B (en) * 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
NZ529671A (en) 2001-06-14 2005-10-28 Akzo Nobel Nv (Pyrido/thieno)-[f]-oxazepin-5-one derivatives
MXPA04004815A (es) * 2001-11-26 2005-02-17 Cortex Pharma Inc Compuestos de carbonilbenzoxazina para mejorar respuestas sinapticas, glutamatergicas.
WO2004022630A2 (en) 2002-09-09 2004-03-18 Nektar Therapeutics Al, Corporation Water-soluble polymer alkanals
EA200501117A1 (ru) 2003-01-13 2006-02-24 Кортекс Фармасеутикалс, Инк. Способ лечения снижения когнитивной способности вследствие лишения сна и стресса
WO2006034196A1 (en) * 2004-09-17 2006-03-30 Lifelike Biomatic Inc. Compositions for enhancing memory and methods therefor
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
US20100234349A1 (en) 2006-09-04 2010-09-16 Olsen Gunnar M Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
EA200900937A1 (ru) * 2007-01-03 2009-12-30 Кортекс Фармасеутикалс, Инк. Соединения 3-замещенного-[1,2,3]бензотриазинона для усиления глутаматергических синаптических ответов
PL2144506T3 (pl) * 2007-01-03 2012-04-30 Servier Lab 3-podstawiony-[1,2,3]-benzotriazynon jako związek do wzmacniania odpowiedzi glutaminianergicznych
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
MX2009009937A (es) * 2007-03-23 2009-09-24 Univ California Tratamiento de la disfuncion sexual femenina mediante compuestos que modulan de manera positiva los receptores de glutamato tipo ampa.
KR101599661B1 (ko) 2007-05-17 2016-03-03 코텍스 파마슈티칼스, 인크. 글루타메이트에 의한 시냅스 반응을 향상시키기 위한 이치환된 아미드 화합물
BRPI0823262A2 (pt) * 2007-08-10 2013-09-24 Cortex Pharma Inc mÉtodo de tratamento de depressço respiratària e uso de um composto na fabricaÇço de um medicamento para o tratamento de depressço respiratària
US8119632B2 (en) 2007-08-10 2012-02-21 Cortex Pharmaceuticals, Inc. Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
US8071914B2 (en) 2007-12-26 2011-12-06 Noboru Oshima Heating apparatus
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
AU2012225784B2 (en) 2011-03-04 2016-03-17 The Regents Of The University Of California Locally released growth factors to mediate motor recovery after stroke
EP3485882A1 (de) 2013-01-25 2019-05-22 Case Western Reserve University Zusammensetzungen zur behandlung von erkrankungen mit pervasiver entwicklung
AU2014277952A1 (en) 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders
CN107286114B (zh) 2016-04-13 2020-08-18 中国人民解放军军事医学科学院毒物药物研究所 Ampa受体增效剂的脑靶向前药及其医药用途
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
EP3731749A4 (de) 2017-12-31 2022-07-27 Neuroenhancement Lab, LLC System und verfahren zur neuroverstärkung zur verbesserung der emotionalen reaktion
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
CN113382683A (zh) 2018-09-14 2021-09-10 纽罗因恒思蒙特实验有限责任公司 改善睡眠的***和方法
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3257396A (en) * 1962-06-11 1966-06-21 Geigy Chem Corp Certain 1, 3-benzoxazinone derivatives
NZ255097A (en) * 1992-07-24 2001-04-27 Univ California Heterocyclic derivatives (such as 1-(1,4-bgenzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine) and medicaments that enhance synaptic responses
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response

Also Published As

Publication number Publication date
NZ331992A (en) 1999-02-25
WO1997036907A1 (en) 1997-10-09
EP0891365A1 (de) 1999-01-20
EP0891365B1 (de) 2002-10-16
DE69716414T2 (de) 2003-06-12
DE69716414D1 (de) 2002-11-21
JP3170294B2 (ja) 2001-05-28
ES2185932T3 (es) 2003-05-01
JP2000503664A (ja) 2000-03-28
AU2427497A (en) 1997-10-22
US5962447A (en) 1999-10-05
US5736543A (en) 1998-04-07
AU708212B2 (en) 1999-07-29
DK0891365T3 (da) 2003-02-10

Similar Documents

Publication Publication Date Title
ATE226206T1 (de) Benzoxazine zur erhöhung der synaptischen reaktionen
PT839134E (pt) Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica
CA2138533A1 (en) Drugs that enhance synaptic responses mediated by ampa receptors
PL341427A1 (en) Benzoxazinic compounds for enhancing sybaptic response
DK1355669T3 (da) Forbedret kognitiv træning
DE69834590D1 (de) Benzofurazanderivate und deren verwendung zur verbesserung glutaminerger synaptischer antworten
DE69910552D1 (de) Acylbenzoxazine zur erhöhung der synaptischen reaktion(en)
EA200400584A1 (ru) Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties